EWS-Fli1 Up-Regulates Expression of the Aurora A and Aurora B Kinases

被引:36
作者
Wakahara, Kazuhiko [1 ]
Ohno, Takatoshi [1 ]
Kimura, Masashi [2 ]
Masuda, Takahiro [1 ]
Nozawa, Satoshi [1 ]
Dohjima, Taikoh [1 ]
Yamamoto, Takatoshi [1 ]
Nagano, Akihito [1 ]
Kawai, Gou [1 ]
Matsuhashi, Aya [1 ]
Saitoh, Mitsuru [1 ]
Takigami, Iori [1 ]
Okano, Yukio [2 ]
Shimizu, Katsuji [1 ]
机构
[1] Gifu Univ, Grad Sch Med, Dept Orthopaed Surg, Gifu 5011194, Japan
[2] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu 5011194, Japan
关键词
D O I
10.1158/1541-7786.MCR-08-0054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EWS-Fli1, a fusion gene resulting from the chromosomal translocation t(11;22, q24;q12), encodes a transcriptional activator, promotes cellular transformation, and is often found in Ewing sarcoma and primitive neuroectodermal tumor. The Aurora A and Aurora B kinases belong to a highly conserved family of serine/threonine protein kinases, are tightly regulated during the cell cycle, and are overexpressed in many carcinomas. Because the relationship between the Aurora A and/or Aurora B genes and the EWS-Fli1 fusion gene is unknown, we investigated the regulatory mechanism(s) by which Aurora kinases are controlled. Knockdown of EWS-Fli1 by small interfering RNA reduced mRNA levels not only of EWS-Fli1 but also of Aurora A and Aurora B. Luciferase assay using Aurora A and Aurora B promoters showed up-regulated activities compared with those of an empty vector. Experiments with deletion and point mutants showed positive regulatory Ets-binding sites located -84 and -71 by upstream of the transcription initiation sites in Aurora A and Aurora B, respectively. Moreover, chromatin immunoprecipitation assay revealed that EWS-Fli1 gene products interact with both the Aurora A and Aurora B promoters. These results strongly suggest that the mitotic kinases Aurora A and Aurora B are regulated by EWS-Fli1 fusion protein in Ewing sarcoma cells. (Mol Cancer Res 2008;6(12):1937-45)
引用
收藏
页码:1937 / 1945
页数:9
相关论文
共 57 条
[51]   Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells [J].
Thompson, AD ;
Teitell, MA ;
Arvand, A ;
Denny, CT .
ONCOGENE, 1999, 18 (40) :5506-5513
[52]   Regulation of Aurora-A kinase gene expression via GABP recruitment of TRAP220/MED1 [J].
Udayakumar, T. S. ;
Belakavadi, Madesh ;
Choi, Kyoung-Han ;
Pandey, Pradeep K. ;
Fondell, Joseph D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (21) :14691-14699
[53]  
Üren A, 2003, ONCOGENE, V22, P2334, DOI 10.1038/sj.onc.1206330
[54]   DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis [J].
Welford, SM ;
Hebert, SP ;
Deneen, B ;
Arvand, A ;
Denny, CT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :41977-41984
[55]   Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer [J].
Yamamoto, Y ;
Matsuyama, H ;
Furuya, T ;
Oga, A ;
Yoshihiro, S ;
Okuda, M ;
Kawauchi, S ;
Sasaki, K ;
Naito, K .
CLINICAL CANCER RESEARCH, 2004, 10 (19) :6449-6455
[56]   Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias [J].
Yi, HK ;
Fujimura, Y ;
Ouchida, M ;
Prasad, DDK ;
Rao, VN ;
Reddy, ESP .
ONCOGENE, 1997, 14 (11) :1259-1268
[57]   Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation [J].
Zhou, HY ;
Kuang, J ;
Zhong, L ;
Kuo, WL ;
Gray, JW ;
Sahin, A ;
Brinkley, BR ;
Sen, S .
NATURE GENETICS, 1998, 20 (02) :189-193